679 related articles for article (PubMed ID: 10826498)
1. Regulation by carnitine of myocardial fatty acid and carbohydrate metabolism under normal and pathological conditions.
Calvani M; Reda E; Arrigoni-Martelli E
Basic Res Cardiol; 2000 Apr; 95(2):75-83. PubMed ID: 10826498
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review.
Ferrari R; Merli E; Cicchitelli G; Mele D; Fucili A; Ceconi C
Ann N Y Acad Sci; 2004 Nov; 1033():79-91. PubMed ID: 15591005
[TBL] [Abstract][Full Text] [Related]
3. Regulation of carbohydrate and fatty acid utilization by L-carnitine during cardiac development and hypoxia.
Abdel-aleem S; St Louis J; Hendrickson SC; El-Shewy HM; El-Dawy K; Taylor DA; Lowe JE
Mol Cell Biochem; 1998 Mar; 180(1-2):95-103. PubMed ID: 9546635
[TBL] [Abstract][Full Text] [Related]
4. Regulation of fatty acid oxidation by acetyl-CoA generated from glucose utilization in isolated myocytes.
Abdel-aleem S; Nada MA; Sayed-Ahmed M; Hendrickson SC; St Louis J; Walthall HP; Lowe JE
J Mol Cell Cardiol; 1996 May; 28(5):825-33. PubMed ID: 8762022
[TBL] [Abstract][Full Text] [Related]
5. Reduced effects of L-carnitine on glucose and fatty acid metabolism in myocytes isolated from diabetic rats.
Abdel-aleem S; Karim AM; Zarouk WA; Taylor DA; el-Awady MK; Lowe JE
Horm Metab Res; 1997 Sep; 29(9):430-5. PubMed ID: 9370110
[TBL] [Abstract][Full Text] [Related]
6. The 1993 Merck Frosst Award. Acetyl-CoA carboxylase: an important regulator of fatty acid oxidation in the heart.
Lopaschuk GD; Gamble J
Can J Physiol Pharmacol; 1994 Oct; 72(10):1101-9. PubMed ID: 7882173
[TBL] [Abstract][Full Text] [Related]
7. Effects of L-carnitine and its acetyl and propionyl esters on ATP and PCr levels of isolated rat hearts perfused without fatty acids and investigated by means of 31P-NMR spectroscopy.
Löster H; Keller T; Grommisch J; Gründer W
Mol Cell Biochem; 1999 Oct; 200(1-2):93-102. PubMed ID: 10569188
[TBL] [Abstract][Full Text] [Related]
8. High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5'-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase.
Kudo N; Barr AJ; Barr RL; Desai S; Lopaschuk GD
J Biol Chem; 1995 Jul; 270(29):17513-20. PubMed ID: 7615556
[TBL] [Abstract][Full Text] [Related]
9. Fatty acid oxidation in the reperfused ischemic heart.
Kantor PF; Dyck JR; Lopaschuk GD
Am J Med Sci; 1999 Jul; 318(1):3-14. PubMed ID: 10408755
[TBL] [Abstract][Full Text] [Related]
10. Regulation of pyruvate dehydrogenase activity and citric acid cycle intermediates during high cardiac power generation.
Sharma N; Okere IC; Brunengraber DZ; McElfresh TA; King KL; Sterk JP; Huang H; Chandler MP; Stanley WC
J Physiol; 2005 Jan; 562(Pt 2):593-603. PubMed ID: 15550462
[TBL] [Abstract][Full Text] [Related]
11. Regulation of carbohydrate metabolism in ischemia and reperfusion.
Lopaschuk G
Am Heart J; 2000 Feb; 139(2 Pt 3):S115-9. PubMed ID: 10650324
[TBL] [Abstract][Full Text] [Related]
12. Carnitine stimulation of glucose oxidation in the fatty acid perfused isolated working rat heart.
Broderick TL; Quinney HA; Lopaschuk GD
J Biol Chem; 1992 Feb; 267(6):3758-63. PubMed ID: 1740427
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of non-oxidative glucose utilization by L-carnitine in isolated myocytes.
Abdel-aleem S; Sayed-Ahmed M; Nada MA; Hendrickson SC; St Louis J; Lowe JE
J Mol Cell Cardiol; 1995 Nov; 27(11):2465-72. PubMed ID: 8596197
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial β-oxidation of saturated fatty acids in humans.
Adeva-Andany MM; Carneiro-Freire N; Seco-Filgueira M; Fernández-Fernández C; Mouriño-Bayolo D
Mitochondrion; 2019 May; 46():73-90. PubMed ID: 29551309
[TBL] [Abstract][Full Text] [Related]
15. Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation.
Dyck JR; Cheng JF; Stanley WC; Barr R; Chandler MP; Brown S; Wallace D; Arrhenius T; Harmon C; Yang G; Nadzan AM; Lopaschuk GD
Circ Res; 2004 May; 94(9):e78-84. PubMed ID: 15105298
[TBL] [Abstract][Full Text] [Related]
16. Effects of propionate and carnitine on the hepatic oxidation of short- and medium-chain-length fatty acids.
Brass EP; Beyerinck RA
Biochem J; 1988 Mar; 250(3):819-25. PubMed ID: 3134008
[TBL] [Abstract][Full Text] [Related]
17. Pyruvate dehydrogenase activity and malonyl CoA levels in normal and ischemic swine myocardium: effects of dichloroacetate.
Stanley WC; Hernandez LA; Spires D; Bringas J; Wallace S; McCormack JG
J Mol Cell Cardiol; 1996 May; 28(5):905-14. PubMed ID: 8762030
[TBL] [Abstract][Full Text] [Related]
18. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase.
Kantor PF; Lucien A; Kozak R; Lopaschuk GD
Circ Res; 2000 Mar; 86(5):580-8. PubMed ID: 10720420
[TBL] [Abstract][Full Text] [Related]
19. Malonyl-CoA decarboxylase inhibition suppresses fatty acid oxidation and reduces lactate production during demand-induced ischemia.
Stanley WC; Morgan EE; Huang H; McElfresh TA; Sterk JP; Okere IC; Chandler MP; Cheng J; Dyck JR; Lopaschuk GD
Am J Physiol Heart Circ Physiol; 2005 Dec; 289(6):H2304-9. PubMed ID: 16100246
[TBL] [Abstract][Full Text] [Related]
20. Effect of ischemia on fatty acid metabolism in fetal lung.
Das DK; Ayromlooi J; Neogi A
Life Sci; 1983 Aug; 33(6):569-76. PubMed ID: 6888185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
